Beijing Scitop Bio-tech Co Ltd
SZSE:300858
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Beijing Scitop Bio-tech Co Ltd
Income from Continuing Operations
Beijing Scitop Bio-tech Co Ltd
Income from Continuing Operations Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Beijing Scitop Bio-tech Co Ltd
SZSE:300858
|
Income from Continuing Operations
¥99.4m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
Inner Mongolia Yili Industrial Group Co Ltd
SSE:600887
|
Income from Continuing Operations
¥8B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
2%
|
CAGR 10-Years
7%
|
|
|
Foshan Haitian Flavouring and Food Co Ltd
SSE:603288
|
Income from Continuing Operations
¥7B
|
CAGR 3-Years
4%
|
CAGR 5-Years
2%
|
CAGR 10-Years
11%
|
|
|
Yihai Kerry Arawana Holdings Co Ltd
SZSE:300999
|
Income from Continuing Operations
¥2.5B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
|
Muyuan Foods Co Ltd
SZSE:002714
|
Income from Continuing Operations
¥10B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
26%
|
|
|
Wens Foodstuff Group Co Ltd
SZSE:300498
|
Income from Continuing Operations
¥2.3B
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-13%
|
|
Beijing Scitop Bio-tech Co Ltd
Glance View
Beijing Scitop Bio-Tech Co., Ltd. develops, produces, and sells probiotic lactic acid bacteria and related products and provides a complete set of product solutions. The company is headquartered in Beijing, Beijing and currently employs 226 full-time employees. The company went IPO on 2020-07-27. The firm's main products include compound food additives, edible probiotic products, animal and plant microecological preparations and others. The firm mainly conducts its businesses within the China market.
See Also
What is Beijing Scitop Bio-tech Co Ltd's Income from Continuing Operations?
Income from Continuing Operations
99.4m
CNY
Based on the financial report for Sep 30, 2025, Beijing Scitop Bio-tech Co Ltd's Income from Continuing Operations amounts to 99.4m CNY.
What is Beijing Scitop Bio-tech Co Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
0%
Over the last year, the Income from Continuing Operations growth was 7%. The average annual Income from Continuing Operations growth rates for Beijing Scitop Bio-tech Co Ltd have been -4% over the past three years .
